Search company, investor...



Other Investors | Alive

About Kspine

Kspine is developing implantable medical devices for the treatment of spine disorders.

Headquarters Location

Missing: Kspine's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Kspine's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Kspine Patents

Kspine has filed 9 patents.

patents chart

Application Date

Grant Date


Related Topics




Spinal nerves, Bones of the vertebral column, Orthopedic surgical procedures, Skeletal disorders, Rare diseases


Application Date


Grant Date



Related Topics

Spinal nerves, Bones of the vertebral column, Orthopedic surgical procedures, Skeletal disorders, Rare diseases



Latest Kspine News

Minnesota medical device company targeting scoliosis raises $2.5 million

Dec 28, 2011

Share / Dec 28, 2011 at 11:33 AM A Minnesota medical device company has raised $2.5 million in its second round of financing, according to a Form D filing with the Securities and Exchange Commission. KSpine’s spinal implant to treat scoliosis requires a less invasive surgical procedure, the company says. Ross Longhini, KSpine’s board chairman, told MedCity News that KSpine will use the investment to fund clinical trials of the device. Scoliosis is typically treated one of two ways — with an external brace or surgical intervention. Longhini said that the company’s device involves fewer screws and only one rod. “One way to characterize it is it requires significantly less hardware. It is a rod but the rod is anchored to the spine using a standard medical screw construct,” Longhini said. KSpine Inc. is led by CEO Fred W. Kornahrens. Longhini, who also is co-founder of Voyageur Medical , an early stage investor in medical device companies said that KSpine has raised $16 million since its launch in early 2008, primarily from two investors — Split Rock Partners in Minneapolis, Minnesota and Abingworth , an investment company targeting life sciences and healthcare, in the United Kingdom. Advertisement The device was developed by Dr. Allen Carl and Dan Sachs, a physician entrepreneur who is a director at KSpine, who also co-founded Cardiac Concepts (now Respicardia) and Mainstay Medical. Scoliosis affects roughly 6 million people in the United States. Other companies are also developing treatments for scoliosis such as SpineForm and Medtronic .

Kspine Frequently Asked Questions (FAQ)

  • What is Kspine's latest funding round?

    Kspine's latest funding round is Other Investors.

  • Who are the investors of Kspine?

    Investors of Kspine include Abingworth.

  • Who are Kspine's competitors?

    Competitors of Kspine include NeuroPace, AxioMed, Flexuspine, SpineLab, Micrus Endovascular and 11 more.

Compare Kspine to Competitors


Gliatech provides devices for the treatment of the nervous system


BioControl - New generation of active implantable devices affecting the behavior of muscles and nerves of the autonomic nervous system. The company sold its urology business for $90M to American Medical Systems.


NanoPowers aims to develop artificial muscles for various implant indications. The Company has developed several animal proof of concepts, and is entering preclinical stages with devices aimed for the treatment of urinary and fecal incontinences.

Applied Spine Technologies

Applied Spine Technologies is a spine company focused on developing implantable dynamic stabilization systems for the treatment of chronic back pain.

Flowonix Medical Logo
Flowonix Medical

Flowonix designs, develops, and deploys targeted drug delivery platforms whose sole purpose is to provide physicians an optimal solution for the treatment of their patients' numerous neurological disorders.

Spinal Restoration

Spinal Restoration restores patients' lives by delivering new therapies that address unmet needs in spine health management. These therapies are minimally invasive, early interventions with clinically proven results. The company is working with a diverse, highly regarded group of clinical and scientific advisors to develop and gain regulatory approval of the Biostat System, a proprietary resorbable biologic and delivery system for the treatment of chronic disc pain, based on solid scientific and clinical evidence.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.